Global TB Diagnostic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 03-Nov-2022
No. of pages: 107
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the TB Diagnostic companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional TB Diagnostic market. Further, it explains the major drivers and regional dynamics of the global TB Diagnostic market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Abbott Laboratories

- Abbott

- Becton Dickinson and Company

- bioMrieux

- Cepheid

- F. Hoffman La Roche

- Hain Lifescience

- Hologic Corporation

- Thermo Fisher Scientific

- Qiagen

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

TB Diagnostic Segment by Type

- Radiographic Method

- Diagnostic Laboratory Methods

- Nucleic Acid Testing

- Phage Assay

- Detection of Latent Infection

- Cytokine Detection Assay

- Detection of Drug Resistance

- Others

TB Diagnostic Segment by Application

- Hospitals

- Clinics

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the TB Diagnostic market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for TB Diagnostic market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of TB Diagnostic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for TB Diagnostic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the TB Diagnostic revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global TB Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for TB Diagnostic revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott Laboratories, Abbott, Becton Dickinson and Company, bioMrieux, Cepheid, F. Hoffman La Roche, Hain Lifescience, Hologic Corporation and Thermo Fisher Scientific, etc.

Global TB Diagnostic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global TB Diagnostic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Radiographic Method
1.2.3 Diagnostic Laboratory Methods
1.2.4 Nucleic Acid Testing
1.2.5 Phage Assay
1.2.6 Detection of Latent Infection
1.2.7 Cytokine Detection Assay
1.2.8 Detection of Drug Resistance
1.2.9 Others
1.3 Market by Application
1.3.1 Global TB Diagnostic Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global TB Diagnostic Market Size (2017-2028)
2.2 TB Diagnostic Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global TB Diagnostic Market Size by Region (2017-2022)
2.4 Global TB Diagnostic Market Size Forecast by Region (2023-2028)
2.5 Global Top TB Diagnostic Countries Ranking by Market Size
3 TB Diagnostic Competitive by Company
3.1 Global TB Diagnostic Revenue by Players
3.1.1 Global TB Diagnostic Revenue by Players (2017-2022)
3.1.2 Global TB Diagnostic Market Share by Players (2017-2022)
3.2 Global TB Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by TB Diagnostic Revenue
3.4 Global TB Diagnostic Market Concentration Ratio
3.4.1 Global TB Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by TB Diagnostic Revenue in 2021
3.5 Global TB Diagnostic Key Players Head office and Area Served
3.6 Key Players TB Diagnostic Product Solution and Service
3.7 Date of Enter into TB Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global TB Diagnostic Breakdown Data by Type
4.1 Global TB Diagnostic Historic Revenue by Type (2017-2022)
4.2 Global TB Diagnostic Forecasted Revenue by Type (2023-2028)
5 Global TB Diagnostic Breakdown Data by Application
5.1 Global TB Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global TB Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America TB Diagnostic Revenue by Company (2020-2022)
6.2 North America TB Diagnostic Revenue by Type (2017-2028)
6.3 North America TB Diagnostic Revenue by Application (2017-2028)
6.4 North America TB Diagnostic Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe TB Diagnostic Revenue by Company (2020-2022)
7.2 Europe TB Diagnostic Revenue by Type (2017-2028)
7.3 Europe TB Diagnostic Revenue by Application (2017-2028)
7.4 Europe TB Diagnostic Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific TB Diagnostic Revenue by Company (2020-2022)
8.2 Asia Pacific TB Diagnostic Revenue by Type (2017-2028)
8.3 Asia Pacific TB Diagnostic Revenue by Application (2017-2028)
8.4 Asia Pacific TB Diagnostic Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America TB Diagnostic Revenue by Company (2020-2022)
9.2 Latin America TB Diagnostic Revenue by Type (2017-2028)
9.3 Latin America TB Diagnostic Revenue by Application (2017-2028)
9.4 Latin America TB Diagnostic Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa TB Diagnostic Revenue by Company (2020-2022)
10.2 Middle East and Africa TB Diagnostic Revenue by Type (2017-2028)
10.3 Middle East and Africa TB Diagnostic Revenue by Application (2017-2028)
10.4 Middle East and Africa TB Diagnostic Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories TB Diagnostic Products and Services
11.1.4 Abbott Laboratories TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.1.5 Abbott Laboratories TB Diagnostic SWOT Analysis
11.1.6 Abbott Laboratories Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott TB Diagnostic Products and Services
11.2.4 Abbott TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.2.5 Abbott TB Diagnostic SWOT Analysis
11.2.6 Abbott Recent Developments
11.3 Becton Dickinson and Company
11.3.1 Becton Dickinson and Company Company Details
11.3.2 Becton Dickinson and Company Business Overview
11.3.3 Becton Dickinson and Company TB Diagnostic Products and Services
11.3.4 Becton Dickinson and Company TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.3.5 Becton Dickinson and Company TB Diagnostic SWOT Analysis
11.3.6 Becton Dickinson and Company Recent Developments
11.4 bioMrieux
11.4.1 bioMrieux Company Details
11.4.2 bioMrieux Business Overview
11.4.3 bioMrieux TB Diagnostic Products and Services
11.4.4 bioMrieux TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.4.5 bioMrieux TB Diagnostic SWOT Analysis
11.4.6 bioMrieux Recent Developments
11.5 Cepheid
11.5.1 Cepheid Company Details
11.5.2 Cepheid Business Overview
11.5.3 Cepheid TB Diagnostic Products and Services
11.5.4 Cepheid TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.5.5 Cepheid TB Diagnostic SWOT Analysis
11.5.6 Cepheid Recent Developments
11.6 F. Hoffman La Roche
11.6.1 F. Hoffman La Roche Company Details
11.6.2 F. Hoffman La Roche Business Overview
11.6.3 F. Hoffman La Roche TB Diagnostic Products and Services
11.6.4 F. Hoffman La Roche TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.6.5 F. Hoffman La Roche TB Diagnostic SWOT Analysis
11.6.6 F. Hoffman La Roche Recent Developments
11.7 Hain Lifescience
11.7.1 Hain Lifescience Company Details
11.7.2 Hain Lifescience Business Overview
11.7.3 Hain Lifescience TB Diagnostic Products and Services
11.7.4 Hain Lifescience TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.7.5 Hain Lifescience TB Diagnostic SWOT Analysis
11.7.6 Hain Lifescience Recent Developments
11.8 Hologic Corporation
11.8.1 Hologic Corporation Company Details
11.8.2 Hologic Corporation Business Overview
11.8.3 Hologic Corporation TB Diagnostic Products and Services
11.8.4 Hologic Corporation TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.8.5 Hologic Corporation TB Diagnostic SWOT Analysis
11.8.6 Hologic Corporation Recent Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific TB Diagnostic Products and Services
11.9.4 Thermo Fisher Scientific TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.9.5 Thermo Fisher Scientific TB Diagnostic SWOT Analysis
11.9.6 Thermo Fisher Scientific Recent Developments
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen TB Diagnostic Products and Services
11.10.4 Qiagen TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.10.5 Qiagen TB Diagnostic SWOT Analysis
11.10.6 Qiagen Recent Developments
12 TB Diagnostic Market Dynamics
12.1 TB Diagnostic Market Trends
12.2 TB Diagnostic Market Drivers
12.3 TB Diagnostic Market Challenges
12.4 TB Diagnostic Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global TB Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Radiographic Method
Table 3. Key Players of Diagnostic Laboratory Methods
Table 4. Key Players of Nucleic Acid Testing
Table 5. Key Players of Phage Assay
Table 6. Key Players of Detection of Latent Infection
Table 7. Key Players of Cytokine Detection Assay
Table 8. Key Players of Detection of Drug Resistance
Table 9. Key Players of Others
Table 10. Global TB Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 11. Global TB Diagnostic Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 12. Global TB Diagnostic Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global TB Diagnostic Revenue Market Share by Region (2017-2022)
Table 14. Global TB Diagnostic Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global TB Diagnostic Market Share by Players (2017-2022)
Table 16. Global Top TB Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Diagnostic as of 2021)
Table 17. Ranking of Global Top TB Diagnostic Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by TB Diagnostic Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players TB Diagnostic Product Solution and Service
Table 21. Date of Key Manufacturers Enter into TB Diagnostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global TB Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global TB Diagnostic Revenue Market Share by Type (2017-2022)
Table 25. Global TB Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global TB Diagnostic Revenue Market Share by Type (2023-2028)
Table 27. Global TB Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global TB Diagnostic Revenue Market Share by Application (2017-2022)
Table 29. Global TB Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global TB Diagnostic Revenue Market Share by Application (2023-2028)
Table 31. North America TB Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 32. North America TB Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 33. North America TB Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 34. North America TB Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 35. North America TB Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 36. North America TB Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 37. North America TB Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 38. Europe TB Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 39. Europe TB Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 40. Europe TB Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 41. Europe TB Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 42. Europe TB Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 43. Europe TB Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 44. Europe TB Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific TB Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 46. Asia Pacific TB Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific TB Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific TB Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific TB Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific TB Diagnostic Revenue by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific TB Diagnostic Revenue by Region (2023-2028) & (US$ Million)
Table 52. Latin America TB Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 53. Latin America TB Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 54. Latin America TB Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 55. Latin America TB Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 56. Latin America TB Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 57. Latin America TB Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 58. Latin America TB Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa TB Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 60. Middle East and Africa TB Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa TB Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa TB Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa TB Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa TB Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa TB Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 66. Abbott Laboratories Company Details
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories TB Diagnostic Product and Services
Table 69. Abbott Laboratories TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 70. Abbott Laboratories TB Diagnostic SWOT Analysis
Table 71. Abbott Laboratories Recent Developments
Table 72. Abbott Company Details
Table 73. Abbott Business Overview
Table 74. Abbott TB Diagnostic Product and Services
Table 75. Abbott TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 76. Abbott TB Diagnostic SWOT Analysis
Table 77. Abbott Recent Developments
Table 78. Becton Dickinson and Company Company Details
Table 79. Becton Dickinson and Company Business Overview
Table 80. Becton Dickinson and Company TB Diagnostic Product and Services
Table 81. Becton Dickinson and Company TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 82. Becton Dickinson and Company TB Diagnostic SWOT Analysis
Table 83. Becton Dickinson and Company Recent Developments
Table 84. bioMrieux Company Details
Table 85. bioMrieux Business Overview
Table 86. bioMrieux TB Diagnostic Product and Services
Table 87. bioMrieux TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 88. bioMrieux TB Diagnostic SWOT Analysis
Table 89. bioMrieux Recent Developments
Table 90. Cepheid Company Details
Table 91. Cepheid Business Overview
Table 92. Cepheid TB Diagnostic Product and Services
Table 93. Cepheid TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 94. Cepheid TB Diagnostic SWOT Analysis
Table 95. Cepheid Recent Developments
Table 96. F. Hoffman La Roche Company Details
Table 97. F. Hoffman La Roche Business Overview
Table 98. F. Hoffman La Roche TB Diagnostic Product and Services
Table 99. F. Hoffman La Roche TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 100. F. Hoffman La Roche TB Diagnostic SWOT Analysis
Table 101. F. Hoffman La Roche Recent Developments
Table 102. Hain Lifescience Company Details
Table 103. Hain Lifescience Business Overview
Table 104. Hain Lifescience TB Diagnostic Product and Services
Table 105. Hain Lifescience TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 106. Hain Lifescience TB Diagnostic SWOT Analysis
Table 107. Hain Lifescience Recent Developments
Table 108. Hologic Corporation Company Details
Table 109. Hologic Corporation Business Overview
Table 110. Hologic Corporation TB Diagnostic Product and Services
Table 111. Hologic Corporation TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 112. Hologic Corporation TB Diagnostic SWOT Analysis
Table 113. Hologic Corporation Recent Developments
Table 114. Thermo Fisher Scientific Company Details
Table 115. Thermo Fisher Scientific Business Overview
Table 116. Thermo Fisher Scientific TB Diagnostic Product and Services
Table 117. Thermo Fisher Scientific TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 118. Thermo Fisher Scientific TB Diagnostic SWOT Analysis
Table 119. Thermo Fisher Scientific Recent Developments
Table 120. Qiagen Company Details
Table 121. Qiagen Business Overview
Table 122. Qiagen TB Diagnostic Product and Services
Table 123. Qiagen TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 124. Qiagen TB Diagnostic SWOT Analysis
Table 125. Qiagen Recent Developments
Table 126. TB Diagnostic Market Trends
Table 127. TB Diagnostic Market Drivers
Table 128. TB Diagnostic Market Challenges
Table 129. TB Diagnostic Market Restraints
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global TB Diagnostic Sales Market Share by Type: 2021 VS 2028
Figure 2. Radiographic Method Features
Figure 3. Diagnostic Laboratory Methods Features
Figure 4. Nucleic Acid Testing Features
Figure 5. Phage Assay Features
Figure 6. Detection of Latent Infection Features
Figure 7. Cytokine Detection Assay Features
Figure 8. Detection of Drug Resistance Features
Figure 9. Others Features
Figure 10. Global TB Diagnostic Sales Market Share by Application: 2021 VS 2028
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. TB Diagnostic Report Years Considered
Figure 15. Global TB Diagnostic Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global TB Diagnostic Market Size 2017-2028 (US$ Million)
Figure 17. Global TB Diagnostic Market Size Market Share by Region: 2021 VS 2028
Figure 18. Global TB Diagnostic Revenue Market Share by Region in 2017 VS 2022
Figure 19. Global Top 10 TB Diagnostic Countries Ranking by Market Size (US$ Million) in 2021
Figure 20. Global TB Diagnostic Market Share by Players in 2021
Figure 21. Global Top TB Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Diagnostic as of 2021)
Figure 22. The Top 10 and 5 Players Market Share by TB Diagnostic Revenue in 2021
Figure 23. North America TB Diagnostic Revenue Market Share by Company in 2021
Figure 24. North America TB Diagnostic Revenue Market Share by Type (2017-2028)
Figure 25. North America TB Diagnostic Revenue Market Share by Application (2017-2028)
Figure 26. North America TB Diagnostic Revenue Share by Country (2017-2028)
Figure 27. U.S. TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 28. Canada TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 29. Europe TB Diagnostic Revenue Market Share by Company in 2021
Figure 30. Europe TB Diagnostic Revenue Market Share by Type (2017-2028)
Figure 31. Europe TB Diagnostic Revenue Market Share by Application (2017-2028)
Figure 32. Europe TB Diagnostic Revenue Share by Country (2017-2028)
Figure 33. Germany TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 34. France TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 35. U.K. TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 36. Italy TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 37. Russia TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 38. Asia Pacific TB Diagnostic Revenue Market Share by Company in 2021
Figure 39. Asia Pacific TB Diagnostic Revenue Market Share by Type (2017-2028)
Figure 40. Asia Pacific TB Diagnostic Revenue Market Share by Application (2017-2028)
Figure 41. Asia Pacific TB Diagnostic Revenue Share by Region (2017-2028)
Figure 42. China TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 43. Japan TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 44. South Korea TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 45. India TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 46. Australia TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 47. Taiwan TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 48. Indonesia TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 49. Thailand TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 50. Malaysia TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 51. Philippines TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 52. Vietnam TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 53. Latin America TB Diagnostic Revenue Market Share by Company in 2021
Figure 54. Latin America TB Diagnostic Revenue Market Share by Type (2017-2028)
Figure 55. Latin America TB Diagnostic Revenue Market Share by Application (2017-2028)
Figure 56. Latin America TB Diagnostic Revenue Share by Country (2017-2028)
Figure 57. Mexico TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 58. Brazil TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 59. Argentina TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 60. Middle East and Africa TB Diagnostic Revenue Market Share by Company in 2021
Figure 61. Middle East and Africa TB Diagnostic Revenue Market Share by Type (2017-2028)
Figure 62. Middle East and Africa TB Diagnostic Revenue Market Share by Application (2017-2028)
Figure 63. Middle East and Africa TB Diagnostic Revenue Share by Country (2017-2028)
Figure 64. Turkey TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 65. Saudi Arabia TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 66. U.A.E TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 67. Abbott Laboratories Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 68. Abbott Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 69. Becton Dickinson and Company Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 70. bioMrieux Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 71. Cepheid Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 72. F. Hoffman La Roche Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 73. Hain Lifescience Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 74. Hologic Corporation Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 75. Thermo Fisher Scientific Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 76. Qiagen Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
  • Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Global Forecast to 2028
    Published: 10-Jan-2024        Price: US 4950 Onwards        Pages: 309
    “Rising focus on decentralized diagnostics is driving the overall growth of the infectious disease diagnostics market.” The infectious disease diagnostics market is valued at an estimated USD 21.4 billion in 2023 and is projected to reach USD 31.5 billion by 2028 at a CAGR of 8.0% during the forecast period. The rising focus on decentralized diagnostics and the growing demand for CLIA-waived PoC tests have driven the use of PoC technologies. The trend towa......
  • Global Pharmaceutical Testing Services Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 102
    Pharmaceutical Testing Service is often used to identify The chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and safety considerations. Pharmaceutical testing can reveal a pharmaceutical's solubility and can predict The medication's ability to reach a specific target within The body. Testing may even reveal contamination in The manufacturing production process or highlight other,......
  • Global Pharmaceutical Testing Services Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Pharmaceutical Testing Services market size was valued at US$ 3398.6 million in 2023. With growing demand in downstream market, the Pharmaceutical Testing Services is forecast to a readjusted size of US$ 7008.4 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Pharmaceutical Testing Services market. Pharmaceutical Testing Services are expected to show ......
  • Global Helicobacter Pylori Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Helicobacter Pylori Diagnostics market size was valued at US$ 624.1 million in 2023. With growing demand in downstream market, the Helicobacter Pylori Diagnostics is forecast to a readjusted size of US$ 1040.4 million by 2030 with a CAGR of 7.6% during review period. The research report highlights the growth potential of the global Helicobacter Pylori Diagnostics market. Helicobacter Pylori Diagnostics are expected to show st......
  • Global Laboratory-developed Testing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Laboratory-developed Testing market size was valued at US$ 3442.2 million in 2023. With growing demand in downstream market, the Laboratory-developed Testing is forecast to a readjusted size of US$ 4512 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Laboratory-developed Testing market. Laboratory-developed Testing are expected to show stable growth i......
  • Global Laboratory-developed Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 109
    According to our (Global Info Research) latest study, the global Laboratory-developed Testing market size was valued at USD 3620.6 million in 2023 and is forecast to a readjusted size of USD 4649.1 million by 2030 with a CAGR of 3.6% during review period. Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vit......
  • Global Pharmaceutical Testing Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 151
    According to our (Global Info Research) latest study, the global Pharmaceutical Testing Services market size was valued at USD 3574.8 million in 2023 and is forecast to a readjusted size of USD 6987.8 million by 2030 with a CAGR of 10.0% during review period. Pharmaceutical Testing Service is often used to identify the chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and s......
  • Global TB Diagnostic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 116
    Market Overview of Global TB Diagnostic market: According to our latest research, the global TB Diagnostic market looks promising in the next 5 years. As of 2022, the global TB Diagnostic market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global TB Diagnostic market, with a sys......
  • IVD Products - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for IVD Products, with both quantitative a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs